文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征患者血白细胞微小RNA表达的时间变化

Temporal Changes in Microrna Expression in Blood Leukocytes from Patients with the Acute Respiratory Distress Syndrome.
PubMed 文献 · Shock · 2017-01-01
一句话结论ARDS患者血白细胞中21种miRNA在起病时升高、第3天持续、第7天进一步升高,且不受全身皮质类固醇影响。

该研究分析了先前一项ARDS皮质类固醇随机试验中51例患者的血白细胞,先用微阵列筛查8例,再以RT-PCR在全部51例中检测25种miRNA。第0天21种miRNA较健康对照升高,第3天仍高,第7天进一步升高(log2倍数变化0.66至5.7倍,与第0天比P<0.05)。亚组分析中皮质类固醇与miRNA表达随时间变化的交互作用不显著,提示全身皮质类固醇对检测的miRNA无影响;而皮质类固醇组第3天IL-6和C反应蛋白下降(P<0.001),第7天两组均下降(P<0.001)。作者认为miRNA在ARDS消退期可能发挥不同的炎症调节作用。

要点

  • ARDS起病第0天即有21种血白细胞miRNA表达升高,第3天持续升高,第7天进一步升高(log2倍数变化0.66至5.7倍,与第0天比P<0.05)。
  • 亚组分析(皮质类固醇37例 vs 安慰剂14例)显示miRNA表达随时间变化与激素使用的交互作用不显著,提示全身皮质类固醇对检测的miRNA无影响。
  • 皮质类固醇组第3天IL-6和C反应蛋白下降(P<0.001),安慰剂组未降,显示早期全身抗炎反应;第7天两组均下降(P<0.001)。
  • 患者第0天APACHE III评分60.4±17.7,PaO2/FiO2 117±49。
  • 作者认为miRNA与皮质类固醇在ARDS消退期可能各自发挥不同的炎症调节作用。

适用人群与场景

  • 来自先前一项ARDS皮质类固醇随机试验的51例患者,其血白细胞被分析。

研究设计与关键结果

  • 研究类型为对先前随机试验储存血白细胞的分析;51例患者,第0天APACHE III评分60.4±17.7,PaO2/FiO2 117±49。
  • 先用微阵列筛查8例,选出25种miRNA,再用RT-PCR在全部51例中检测。
  • 第0天21种miRNA在血白细胞中较健康对照表达升高,第3天仍升高,第7天进一步升高(log2倍数变化0.66至5.7倍,与第0天比P<0.05)。
  • 亚组分析(皮质类固醇37例 vs 安慰剂14例)中,miRNA表达随时间变化与激素使用的交互作用不显著,提示全身皮质类固醇对检测的miRNA无影响。
  • 皮质类固醇组第3天IL-6和C反应蛋白下降(P<0.001),安慰剂组未降;第7天两组均下降(P<0.001)。

证据类型、等级与局限

  • 证据类型:对先前随机试验血白细胞的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为miRNA与皮质类固醇在ARDS消退期可能各自发挥不同的炎症调节作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: MicroRNA (miRNA) control gene transcription by binding to and repressing the translation of messenger RNA (mRNA). Their role in the acute respiratory distress syndrome (ARDS) is undefined.

METHODS: Blood leukocytes from 51 patients enrolled in a prior randomized trial of corticosteroids for ARDS were analyzed. After screening eight patients with microarrays for altered miRNA expression, 25 miRNAs were selected for further analysis using RT-PCR in all 51 patients.

RESULTS: On day 0, the 51 patients had APACHE III score of 60.4 ± 17.7 and PaO2/FiO2 of 117 ± 49. 21 miRNA were expressed at increased levels in blood leukocytes at the onset of ARDS compared with healthy controls. These miRNA remained elevated at day 3 and increased further by day 7 (log2 fold change from 0.66 to 5.7 fold, P <0.05 compared to day 0). In a subgroup analysis (37 patients treated with corticosteroids and 14 treated with placebo), the interaction of miRNA expression over time and steroid administration was not significant suggesting that systemic corticosteroids had no effect on the miRNA detected in our study. In contrast, corticosteroids but not placebo decreased IL-6 and C-reactive protein at day 3 (P < 0.001) demonstrating an early systemic anti-inflammatory response whereas both treatment arms had decreased values by day 7 (P <0.001).

CONCLUSIONS: Expression of miRNA is increased in blood leukocytes of patients with ARDS at day 0 and day 3 and rises further by day 7, when systemic inflammation is subsiding. These effects appear independent of the administration of steroids, suggesting different inflammatory modifying roles for each in the resolving phases of ARDS.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Narute P, Seam N, Tropea M, et al. Temporal Changes in Microrna Expression in Blood Leukocytes from Patients with the Acute Respiratory Distress Syndrome. Shock. 2017. PMID: 27879560. doi:10.1097/SHK.0000000000000806

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。